Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-18 4:03 pm Purchase |
2025-02-13 | 13G | Indaptus Therapeutics, Inc. INDP |
YA II PN, Ltd. | 1,410,916 9.990% |
1,410,916 (New Position) |
Filing History |
| 2024-11-26 4:11 pm Purchase |
2024-11-22 | 13D | Indaptus Therapeutics, Inc. INDP |
Meckler Jeffrey A | 875,704 6.900% |
85,106 (+10.76%) |
Filing History |
| 2024-10-10 4:10 pm Purchase |
2023-08-04 | 13D | Indaptus Therapeutics, Inc. INDP |
Meckler Jeffrey A | 790,598 7.300% |
790,598 (New Position) |
Filing History |
| 2023-08-16 5:57 pm Purchase |
2023-08-14 | 13G | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 1,190,400 14.170% |
103,352 (+9.51%) |
Filing History |
| 2022-07-07 7:40 pm Purchase |
2022-06-27 | 13G | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 1,087,048 13.160% |
348,956 (+47.28%) |
Filing History |
| 2022-02-11 07:14 am Purchase |
2021-12-31 | 13G | Indaptus Therapeutics, Inc. INDP |
Mitchell P. Kopin | 60,232 0.700% |
60,232 (New Position) |
Filing History |
| 2021-11-17 09:00 am Purchase |
2021-09-29 | 13D | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 738,092 9.000% |
209,852 (+39.73%) |
Filing History |
| 2021-10-26 5:17 pm Unchanged |
2021-09-29 | 13D | Indaptus Therapeutics, Inc. INDP |
Newman Michael James | 1,388,356 16.900% |
0 (Unchanged) |
Filing History |
| 2021-10-26 5:16 pm Purchase |
2021-09-29 | 13D | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 528,240 6.400% |
115,718 (+28.05%) |
Filing History |
| 2021-10-26 5:16 pm Unchanged |
2021-09-29 | 13D | GAN Limited GAN |
Lee Hoonmo | 694,522 8.400% |
0 (Unchanged) |
Filing History |
| 2021-08-19 4:05 pm Purchase |
2021-08-03 | 13D | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 412,522 7.600% |
412,522 (New Position) |
Filing History |
| 2021-08-13 5:25 pm Purchase |
2021-08-03 | 13D | GAN Limited GAN |
Lee Hoonmo | 694,522 12.800% |
694,522 (New Position) |
Filing History |
| 2021-08-13 3:50 pm Purchase |
2021-08-03 | 13D | Indaptus Therapeutics, Inc. INDP |
Newman Michael James | 1,388,356 25.700% |
1,388,356 (New Position) |
Filing History |